Previous studies have reported that HKR3 inhibits ARF expression and cell proliferation in the ARF region 36,37, indicating that among various tumor-suppressing functions, HKR3 also acts as a regulator of the cell cycle, which is controlled by ARF and cell proliferation 19,36,38,39. This evidence concerns the gene CDKN2A and neoplasm.